基金经理：刘海燕
| 单位净值:0.8427 | 净值增长率:-1.55% | 净值增长率:-1.55% | 累计净值:0.8427 | 截止日期:2026/10/14 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.11亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
富国国证疫苗与生物科技ETF发起式联接A(021280)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2026/6/30 | 11,257,200 | 13,186,800 | 5,251,180 | 3,321,630 | 1,929,550 | 17.14% |
| 2026/6/30 | 12,471,800 | 13,186,800 | 2,136,350 | 1,421,370 | 714,980 | 5.73% |
| 2026/3/31 | 11,257,200 | 12,471,800 | 3,114,830 | 1,900,260 | 1,214,570 | 10.79% |
| 2025/12/31 | 10,175,100 | 11,257,200 | 6,395,930 | 5,313,850 | 1,082,080 | 10.63% |
| 2025/12/31 | 11,346,500 | 11,257,200 | 970,347 | 1,059,660 | -89,313 | -0.79% |
| 2025/9/30 | 10,531,200 | 11,346,500 | 4,356,020 | 3,540,700 | 815,320 | 7.74% |
| 2025/6/30 | 10,175,100 | 10,531,200 | 1,069,560 | 713,480 | 356,080 | 3.5% |
| 2025/6/30 | 10,151,200 | 10,531,200 | 820,002 | 440,028 | 379,974 | 3.74% |
| 2025/3/31 | 10,175,100 | 10,151,200 | 249,562 | 273,452 | -23,890 | -0.23% |
| 2024/12/31 | 10,013,500 | 10,175,100 | 824,103 | 662,422 | 161,681 | 1.61% |
| 2024/12/31 | 10,280,400 | 10,175,100 | 457,375 | 562,640 | -105,265 | -1.02% |
| 2024/9/30 | 10,016,800 | 10,280,400 | 361,340 | 97,782 | 263,558 | 2.63% |
| 2024/6/30 | 10,013,500 | 10,016,800 | 5,389 | 2,000 | 3,388 | 0.03% |
| 2024/6/30 | 10,013,500 | 10,016,800 | 5,389 | 2,000 | 3,388 | 0.03% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。